SecBot SecBot
8-K ·Filed Aug 19, 2026

FOCL

EDAP TMS SA
BEARISH
Impact 6/10
Horizonimmediate Processed2mo ago SEC0001104659-26-098487
8-K context-dependent: Items 8.01
Actionable Insight ▼ Bearish

The full exercise of the over-allotment option adds ~15% more shares on top of the initial 29% dilutive offering, for total dilution of ~44% from pre-offering levels. Monitor for further share price pressure as the additional 1.26M ADSs hit the market on August 19. The $5.6M net proceeds provide a modest cash buffer but do not offset the substantial dilution to existing holders.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.36
T+0 close · Aug 19, 2026 · via day close
Latest settled
−21.79%
T+60 · $3.41
Vs SPY
−20.24%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 19 $4.36entry
  2. T+1 · 3mo ago −3.21%α −2.37% · $4.22
  3. T+5 · 3mo ago +1.15%α +1.53% · $4.41
  4. T+20 · 2mo ago −1.83%α +0.12% · $4.28
  5. T+60 · 5d ago −21.79%α −20.24% · $3.41

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

EDAP TMS SA reports that underwriters fully exercised their option to purchase an additional 1,263,750 ADSs in the company's public offering at $4.75 per ADS, expected to close August 19, 2026, generating approximately $5.6 million in net proceeds. This represents incremental dilution of ~15% on top of the initial 8.425M ADS offering, increasing total shares sold to ~9.7M ADSs for gross proceeds of ~$46M.

Key Facts

  • Underwriters fully exercised the option to purchase an additional 1,263,750 ADSs at $4.75 per ADS.
  • The additional issuance is expected to close on August 19, 2026.
  • Expected net proceeds from the option exercise are approximately $5.6 million.
  • Total offering: 8,425,000 ADSs initially plus 1,263,750 additional = ~9.7M ADSs.
  • Offering price was $4.75 per ADS.
  • Market cap is ~$160M; the total offering represents ~29% dilution at the offering price.

Financial Impact

Incremental dilution of ~15% from the option exercise, adding ~$5.6M net to the company's cash balance. Total offering dilution of ~29% relative to pre-offering share count.

dilutioncash

Risk Factors

  • Significant dilution to existing shareholders from the combined ~9.7M ADS offering.
  • Potential near-term selling pressure as additional shares are issued and distributed.
  • No operational or financial update provided to justify the capital raise.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
73% bullish (11 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-098487
Document: tm2623508d1_ex5-1.htm0001104659-26-098487
Document: 0001104659-26-098487-index-headers.html0001104659-26-098487
Document: 0001104659-26-098487-index.html0001104659-26-098487
Document: 0001104659-26-098487.txt0001104659-26-098487

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 19, 2026